微创手术取注射式隆乳剂聚丙烯酰胺水凝胶35例

朱婧; 朱大江; 陈双全; 马诺; 宋锦文

doi:10.3969/j.issn.1674-4500.2014.04.07

微创手术取注射式隆乳剂聚丙烯酰胺水凝胶35例

doi: 10.3969/j.issn.1674-4500.2014.04.07

佛山市妇幼保健院乳腺疾病防治中心，广东佛山 528000

详细信息

作者简介:
朱婧，主治医师，E-mail: zjsmalll@vip.sina.com

计量
- 文章访问数: 591
- HTML全文浏览量: 231
- PDF下载量: 3
- 被引次数: 0
出版历程
- 收稿日期: 2014-06-18
- 刊出日期: 2014-10-01

Remove injection augmentation agent polyacrylamide hydrogel by minimally invasive surgery 35 cases report

The Center of Breast Diseases, Maternal and Children Healthcare Hospital of Foshan City, Foshan 528000, China

摘要

摘要: 目的探讨注射式隆乳剂聚丙烯酰胺水凝胶微创手术取出的可行性并总结手术经验。方法35例共58只乳腺注射式隆乳剂PAHG患者，32例共52只乳房在腔镜辅助下行取出术，3例共5只乳腺PAHG位于腺体内或皮下，通过麦默通微创取出，对切口选择、手术效果及手术经验进行总结。结果52只乳房PAHG注射式隆乳剂在腔镜辅助下绝大部分被取出，术后3~6月随访，高频超声检查48只乳腺未发现PAHG残留，4只乳房外下象限见少量PAHG残留，其中2只乳房合并腺体内PAHG无回声结节。5只乳房行麦默通微创手术取出，术后3~6月随访未发现PAHG残留。结论微创腔镜辅助下注射隆胸PAHG取出术可去除后间隙大部分PAHG，对于腺体内或皮下PAHG可行麦默通微创手术取出，手术损伤小，安全、可靠，术后切口美观，在临床上有一定的应用价值。
- 聚丙烯酰胺水凝胶 /
- 注射式隆乳 /
- 腔镜 /
- 麦默通 /
- 微创
Abstract: Objective To explore the feasibility and conclude experiment of an operation in which removing the injection augmentation agent polyacrylamide hydrogel under minimally invasive surgery. Methods All 58 breasts in 35 patients were removed PAHG, 52 breasts in 32 patients with endoscope-assisted and 5 breasts in 3 patients whose injection located in the subcutaneous or mammary gland were removed by mammotome. It has draw a conclusion about the selection of the best incision and effect and experiment of operation. Results A majority of polyacrylamide hydrogel be removed under endoscope-assisted in 52 breast. Follow-up 3 to 6 months by high frequency ultrasound, showed no discovered polyacrylamide hydrogel in 48 breasts, but in 4 breasts were discovered located in the subcutaneous and 2 of them complicated with no echo nodules in mammary gland. 5 breasts revomed the injection by mammotome, follow-up 3 to 6 months showed no discovered. Conclusion A majority of polyacrylamide hydrogel may be removed under endoscope-assisted. In cases of few polyacrylamide hydrogel left in mammary gland or subcutaneous, can be removed by mammotome. It is safe and feasible and gives good cosmetic results remove of polyacrylamide hydrogel under minimally invasive surgery. We believe that offers other selections of removing breast polyacrylamide hydrogel injection.
- polyacrylamide hydrogel /
- injected augmentation mammaplasty /
- endoscope /
- Mammotome /
- minimally invasive surgery

HTML全文

参考文献(18)

[1]	国家食品药品监督管理局. 国家食品药品监督管理局关于停止生产, 销售和使用聚丙烯酰胺水凝胶(注射用)的通告[S]. 2006.
[2]	岳颖, 栾杰, 乔群, 等. 聚丙烯胺水凝胶注射隆乳并发症90例[J]. 中华整形外科杂志, 2007, 23(3): 221-3.
[3]	霍孟华, 黄金井, 戚可名. 聚丙烯酰胺水凝胶毒副作用的实验研究[J]. 中华整形外科杂志, 2002, 18(2): 79-80. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHZX200202005.htm
[4]	王毓璈, 杨天鹏, 应奇才, 等. 聚丙烯酰胺水凝胶注入兔体的免疫效应研究[J]. 中华医学美学美容杂志, 2002, 8(3): 146-8. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHMR200203011.htm
[5]	Cheng NX, Wang YL, Wang JH, et al. Complications of breast augmentation with injected hydrophilic polyacrylamide gel[J]. Aesthetic Plast Surg, 2002, 26(5): 375-82. doi: 10.1007/s00266-002-2052-4
[6]	Mucci LA, Dickman PW, Steineck G, et al. Dietary acrylamide and Cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden[J]. Br J Cancer, 2003, 88(1): 84-9. doi: 10.1038/sj.bjc.6600726
[7]	孙家明, 李薇薇, 张一鸣, 等. 聚丙烯酰胺水凝胶注射术后并发症原因初探[J]. 中国药物警戒, 2006, 3(2): 97-9. http://www.cnki.com.cn/Article/CJFDTOTAL-YWJJ200602009.htm
[8]	陈国勤, 刘蓉, 顾莹莹. 硅胶注射隆乳术后出现乳腺癌病理分析[J]. 中华整形外科杂志, 2004, 20(5): 330-2. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHZX200405003.htm
[9]	Cheng NX, Liu LG, Hui L, et al. Breast Cancer following augmentation mammaplasty with polyacrylamide hydrogel (PAAG) injection[J]. Aesthetic Plast Surg, 2009, 33(4): 563-9. doi: 10.1007/s00266-008-9298-4
[10]	王慕, 王晓阳, 侯晓冬, 等. 聚丙烯酰胺水凝胶注射后伴发乳房恶性肿瘤:2例报道[J]. 中国组织工程研究与临床康复, 2010, 14(8): 1488-90. http://www.cnki.com.cn/Article/CJFDTOTAL-XDKF201008055.htm
[11]	Xi TF, Fan CX, Feng XM, et al. Cytotoxicity and altered c-myc gene expression by medical polyacrylamide hydrogel[J]. J Biomed Mater Res A, 2006, 78(2): 283-90. http://cn.bing.com/academic/profile?id=1980516560&encoded=0&v=paper_preview&mkt=zh-cn
[12]	孙艳花, 宋建明, 温文, 等. 注射聚丙烯酰胺水凝胶隆乳后的乳腺病变[J]. 中国组织工程研究与临床康复, 2011, 15(25): 4623-6. http://www.cnki.com.cn/Article/CJFDTOTAL-XDKF201125022.htm
[13]	沈尊理, 贾万新, 蔡嬿娴, 等. 聚丙烯酰胺水凝胶注射隆乳术后并发症处理临床分析[J]. 组织工程与重建外科杂志, 2007, 3(3): 154-6. http://www.cnki.com.cn/Article/CJFDTOTAL-ZZCW200703015.htm
[14]	胡华新, 刘学军, 朱辉, 等. 聚丙烯酰胺水凝胶注射隆乳不良反应的临床观察[J]. 中华整形外科杂志, 2002, 18(2): 81-2. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHZX200202006.htm
[15]	吕仁荣, 吴军成, 林玲玲, 等. 聚丙烯酰胺水凝胶注射隆乳严重移位一例[J]. 中华整形外科杂志, 2011, 27(5): 390-1.
[16]	唐庆, 苏爱云, 古健, 等. 内窥镜辅助清除聚丙烯酰胺水凝胶注射隆乳术后异物并一期假体置入[J]. 中华整形外科杂志, 2006, 22(3): 183-5. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHZX200603013.htm
[17]	范林军, 姜军, 杨新华, 等. 腔镜技术在隆乳剂取出术中的应用:附45例报道[J/OL]. 中华乳腺病杂志: 电子版, 2009, 3(6): 600-9.
[18]	朱大江, 周志升, 郭钊轩, 等. 腔镜手术取乳房注射隆胸材料聚丙烯酰胺水凝胶[J]. 中国美容医学, 2012, 21(3): 365-7. http://www.cnki.com.cn/Article/CJFDTOTAL-MRYX201203008.htm

施引文献

资源附件(0)

访问统计

点击查看大图

计量

文章访问数: 591
HTML全文浏览量: 231
PDF下载量: 3
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

微创手术取注射式隆乳剂聚丙烯酰胺水凝胶35例

doi: 10.3969/j.issn.1674-4500.2014.04.07

作者简介:
朱婧，主治医师，E-mail: zjsmalll@vip.sina.com

计量

Remove injection augmentation agent polyacrylamide hydrogel by minimally invasive surgery 35 cases report

计量

目录

留言板

微创手术取注射式隆乳剂聚丙烯酰胺水凝胶35例

doi: 10.3969/j.issn.1674-4500.2014.04.07

作者简介: 朱婧，主治医师，E-mail: zjsmalll@vip.sina.com

计量

出版历程

Remove injection augmentation agent polyacrylamide hydrogel by minimally invasive surgery 35 cases report

计量

出版历程

目录

作者简介:
朱婧，主治医师，E-mail: zjsmalll@vip.sina.com